These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28705110)

  • 1. An unusual indication for subcutaneous implantable -cardioverter/defibrillator.
    De Schryver N; van Ruyssevelt C; Capulzini L
    Acta Cardiol; 2017 Aug; 72(4):487-488. PubMed ID: 28705110
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac metastasis causing right bundle branch block and recurrent septal ventricular tachycardia.
    Badri M; Bradley J; Ju R; Yan GX
    J Cardiovasc Electrophysiol; 2014 Jul; 25(7):793-4. PubMed ID: 24612005
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardioverter-defibrillator implantation to treat cardiac fibroma-induced ventricular tachycardia in a 70-year-old woman.
    Hakim FA; Pandit A; Mookadam F; Mamby S
    Tex Heart Inst J; 2014 Jun; 41(3):329-31. PubMed ID: 24955056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.
    Francia P; Adduci C; Palano F; Semprini L; Serdoz A; Montesanti D; Santini D; Musumeci B; Salvati A; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):893-899. PubMed ID: 25996259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External implantable defibrillator as a bridge to reimplant after implantable cardioverter-defibrillator explant.
    Dell'Era G; Magnani A; Occhetta E
    Europace; 2015 Nov; 17(11):1726. PubMed ID: 26462698
    [No Abstract]   [Full Text] [Related]  

  • 6. Technique for subcutaneous implantable cardioverter-defibrillator extraction.
    Ip JE
    J Cardiovasc Electrophysiol; 2019 May; 30(5):789-791. PubMed ID: 30815922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate implantable cardioverter-defibrillator therapy during exercise: what is the mechanism?
    Vollmann D; Lüthje L; Zabel M
    Heart Rhythm; 2009 May; 6(5):718-9. PubMed ID: 19303370
    [No Abstract]   [Full Text] [Related]  

  • 8. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
    Kwok SY; Yam N; Lun KS; Chen RH; Au TW; Yung TC
    Europace; 2018 Sep; 20(FI2):f248. PubMed ID: 29401320
    [No Abstract]   [Full Text] [Related]  

  • 9. The challenge of implantable cardioverter-defibrillator programming and shock interpretation in treatment-refractory catecholaminergic polymorphic ventricular tachycardia.
    Roston TM; Hart A; Krahn AD; Sanatani S
    J Cardiovasc Med (Hagerstown); 2019 Aug; 20(8):569-571. PubMed ID: 31090560
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple morphologies of ventricular tachycardia assessed by implantable cardioverter-defibrillator electrograms in a patient with Chagas disease, successfully treated with catheter ablation: modern problems, old solutions.
    Hadid C; Gallino S; Di Toro D; Celano L; Lopez C; Duce E; Labadet C
    Europace; 2012 Nov; 14(11):1660. PubMed ID: 22581623
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple ICD shocks in a patient with dilated cardiomyopathy: What is the mechanism?
    Fontenla A; López-Gil M; Rodríguez Muñoz D; Díez de Las Heras D; Arribas F
    J Cardiovasc Electrophysiol; 2019 May; 30(5):781-784. PubMed ID: 30688386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repetitive shock therapy of subcutaneous implantable cardioverter defibrillators in a patient with idiopathic ventricular fibrillation: What is the mechanism?
    Hasegawa K; Miyazaki S; Ishikawa E; Mukai M; Aoyama D; Nodera M; Kaseno K; Tada H
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2121-2124. PubMed ID: 31332856
    [No Abstract]   [Full Text] [Related]  

  • 15. An electrical storm with more than 3000 shocks in a patient with an implantable cardioverter-defibrillator: is jet-lag a trigger?
    Han SW; Kim YN; Lee YS; Hyun DW; Kim D; Hur SH; Kim KS; Kim KB
    Int J Cardiol; 2005 Sep; 104(2):235-7. PubMed ID: 16168822
    [No Abstract]   [Full Text] [Related]  

  • 16. Aborted sudden cardiac death: ICD or no ICD.
    Lachmann V; Makimoto H; Kelm M; Bönner F
    Clin Res Cardiol; 2017 Sep; 106(9):760-763. PubMed ID: 28396986
    [No Abstract]   [Full Text] [Related]  

  • 17. Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes.
    Bradfield J; Tung R; Boyle NG; Shivkumar K
    Heart Fail Rev; 2011 Sep; 16(5):449-56. PubMed ID: 21451976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inappropriate shock delivery by implantable cardioverter defibrillator due to electrical leak from bathroom tap.
    Camsarı A; Yılmaz DC; Ozcan T
    Clin Res Cardiol; 2010 Nov; 99(11):761-3. PubMed ID: 20683725
    [No Abstract]   [Full Text] [Related]  

  • 20. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
    Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.